Moving classes outside deserves serious consideration not only for better ventilation, but also to introduce more education devoted to learning on, from and with the land.
Women are increasingly taking more visible senior roles in leadership. This reflects their ability to effectively manage difficult situations, as demonstrated by Chrystia Freeland and Kamala Harris.
Reports describe a Hong Kong man who was reinfected with the coronavirus after returning from Europe. Does that mean he wasn’t immune after the first infection?
Current rates of vaccine hesitancy could jeopardize efforts to achieve herd immunity in the US, says Matt Motta, a political scientist who studies vaccine uptake and effective health communication.
School nurses were already overwhelmed, with hundreds of students and staff in their charge. Now, COVID-19 screenings and testing have become their priority.
New research points to why reopening elementary schools is the safest bet and what else needs to happen for schools to have the best chance of staying open.
In the middle of the pandemic, the Trump administration is pursuing policy and a court ruling that would take away health care from millions. Two scholars explain the details.
With Justice Rangiah finding the border closures are safer in stopping the spread of COVID-19 than alternatives, Palmer will now take his challenge to the High Court on constitutional grounds.
An extension of Victoria’s state of emergency may well be justified – but there is no call for that to be for 12 months without returning to parliament to argue the case.
The government continues to pledge funds for the aged-care sector in the face of COVID-19. But this is damage control rather than what we actually need — a co-ordinated, evidence-based national plan.
QAnon is gaining ground in Australia due to a growing distrust in the government and media, part of which is rooted in a perceived lack of transparency over the coronavirus response and restrictions.
The Postal Service plays a critical role in the supply chains of small businesses and in keeping rural America connected. There’s no reason it can’t continue to do so despite its financial woes.
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
Thousands of people around the world have said they are willing to be exposed to COVID-19 to test new vaccines. Since we don’t fully understand the long-term effects of the disease, is this ethical?
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne